1-3 of 3
Rebecca L. Auer, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

R2W: Subcutaneous Bortezomib, Cyclophosphamide and Rituximab (BCR) Versus Fludarabine, Cyclophosphamide and Rituximab (FCR) for Initial Therapy of WaldenstrőM's Macroglobulinemia: A Randomised Phase II Study

Rebecca L Auer, MD PhD, Roger G Owen, Shirley D'Sa, Guy Pratt, MD FRCP FRCPath, Bilyana Popova, Laura Clifton Hadley, Oliver Schofield, Nicholas Counsell, Paul Smith
Journal: Blood
Blood (2016) 128 (22): 618.
https://doi.org/10.1182/blood.V128.22.618.618
Published: 2016
Journal Articles

The 13q and 11q B-Cell Chronic Lymphocytic Leukemia Deleted Regions Derive from a Common Ancestral Region in the Zebrafish on Linkage Group 9.

Rebecca L. Auer, MD, PhD, Sophia Riaz, BSc, Finbarr E. Cotter, MD PhD
Journal: Blood
Blood (2006) 108 (11): 295.
https://doi.org/10.1182/blood.V108.11.295.295
Published: 2006
Journal Articles

GCS-100, a Galectin 3 Antagonist, Is a Novel Caspase-9 Apoptosis Activating Agent for the Treatment of Indolent B-Cell Malignancies.

Finbarr E. Cotter, MD PhD, Bo Su, MD, Margherita Corbo, BSc, Y. Chang, Joanne Schindler, Brad Carver, Christopher D. Fegan, MD, Adrian C. Newland, MD, Rebecca L. Auer, MD PhD
Journal: Blood
Blood (2004) 104 (11): 3286.
https://doi.org/10.1182/blood.V104.11.3286.3286
Published: 2004